Patient Note — 249811

progress_notes_249811_1_deid.txt

← Back to all patients Run PA Decision for this patient →

Demographics & Encounter

Patient ID249811 (PHI redacted)
Age / Gender71 / Male
Date of Service2025-12-17
Provider[PROVIDER_NAME]
FacilityPOTOMAC UROLOGY CENTER - Woodbridge
PayerMedicare VA
Reason1. UROCUFF REVIEW

Diagnoses

N40.0 BPH loc w/o ur obs/LUTS
R35.1 Nocturia
N20.0 Calculus of kidney

Medications

Potassium Citrate ER 10 MEQ (1080 MG) Tablet Extended Release 1 tablet with meals Orally Three times a day Farxiga(Dapagliflozin Propanediol) Lipitor(Atorvastatin Calcium) Allopurinol Norvasc Progress Note: [PROVIDER_NAME], MD 12/17/2025 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/16/2026 03:35 AM EDT 1/3 4/16/26, 12:35 AM Print Preview [PATIENT_NAME] DOB: [DOB] (71 yo M) Acc No. [ACCOUNT_ID] DOS: 12/17/2025 Synthroid(Levothyroxine Sodium) Vitamin D Medication List reviewed and reconciled with the patient

Past Medical History

  • Kidney Stone
  • Thyroid disease
  • Gout
  • Hypertension
  • High Cholesterol

Vitals

RR 16.0
HR 86.0
BP 141/76
BMI 25.84
WEIGHT 165 lbs
HEIGHT_IN 67.0

Clinical Summary (HPI)

BPH screening: 71yM patient with history of BPH presents here today for a 1 month follow up with Urocuff review. ---------------------------- The patient's previous work-up history is listed below: PSA: 0.46 ng/ml [04/15/2025] DRE: 40gm, Smooth [04/15/2025] Transvesical Pelvic Ultrasound: Enlarged and Heterogenous prostate gland with a prominent median lobe and small calcifications. Urocuff information Date 12/16/2025 Peak flow (mL/s) 11.3 Volume voided (cc) 331 Bladder pressure (cm H2O) 161.0 PVR (mL) 16 Category high pressure/high flow Kidney Stone: Also, with history of Kidney stones. +++++ 24 hr/Litholink: Suboptimal urine volume. Hypomagnesiuria may contribute to calcium stone formation. Marked hypocitraturia. [02-24-2025] Stone Analysis: Calcium oxalate monohydrate (90%), Calcium oxalate dihydrate (10%) [02/27/2025] PTH: 84.1 pg/mL [02/20/2025] Uric Acid, serum: 6.3 mg/dl [02/20/2025] Calcium: 9.4 mg/dl [02/20/2025] CT A/P WO shows obstructing 4 mm left UVJ stone. Small bilateral renal calculi. [2/17/2025].

Raw Note (de-identified preview)

4/16/26, 12:35 AM Print Preview [PATIENT_NAME] DOB: [DOB] (71 yo M) Acc No. [ACCOUNT_ID] DOS: 12/17/2025 [PATIENT_NAME] 71 Y old Male, DOB: [DOB] Account: [ACCOUNT_ID] [ADDRESS] Home: [PHONE] Guarantor: [GUARANTOR_NAME] Insurance: Medicare VA (Palmetto) PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME] Appointment Facility: POTOMAC UROLOGY CENTER - Woodbridge 12/17/2025 Progress Notes: [PROVIDER_NAME], MD Reason for Appointment 1. UROCUFF REVIEW History of Present Illness BPH screening: 71yM patient with history of BPH presents here today for a 1 month follow up with Urocuff review. ---------------------------- The patient's previous work-up history is listed below: PSA: 0.46 ng/ml [04/15/2025] DRE: 40gm, Smooth [04/15/2025] Transvesical Pelvic Ultrasound: Enlarged and Heterogenous prostate gland with a prominent median lobe and small calcifications. Urocuff information Date 12/16/2025 Peak flow (mL/s) 11.3 Volume voided (cc) 331 Bladder pressure (cm H2O) 161.0 PVR (mL) 16 Category high pressure/high flow Kidney Stone: Also, with history of Kidney stones. +++++ 24 hr/Litholink: Suboptimal urine volume. Hypomagnesiuria may contribute to calcium stone formation. Marked hypocitraturia. [02-24-2025] Stone Analysis: Calcium oxalate monohydrate (90%), Calcium oxalate dihydrate (10%) [02/27/2025] PTH: 84.1 pg/mL [02/20/2025] Uric Acid, serum: 6.3 mg/dl [02/20/2025] Calcium: 9.4 mg/dl [02/20/2025] CT A/P WO shows obstructing 4 mm left UVJ stone. Small bilateral renal calculi. [2/17/2025]. Current Medications Taking Potassium Citrate ER 10 MEQ (1080 MG) Tablet Extended Release 1 tablet with meals Orally Three times a day Farxiga(Dapagliflozin Propanediol) 10 MG Tablet 1 tablet Orally Once a day Lipitor(Atorvastatin Calcium) 40 MG Tablet 1 tablet Orally Once a day Allopurinol 100 MG Tablet 1 tablet Orally Once a day Norvasc 10 MG Tablet 1 tablet Orally Once a day Progress Note: [PROVIDER_NAME], MD 12/17/2025 Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com) Generated for Printing/Faxing/eTransmitting on: 04/16/2026 03:35 AM EDT 1/3 4/16/26, 12:35 AM Print Preview [PATIENT_NAME] DOB: [DOB] (71 yo M) Acc No. [ACCOUNT_ID] DOS: 12/17/2025 Synthroid(Levothyroxine Sodium) 25 MCG Tablet 1 tablet in the morning on an empty stomach Orally Once a day Vitamin D Medication List reviewed and reconciled with the patient Past Medical History Kidney Stone. Thyroid disease. Gout. Hypertension. High Cholesterol. Surgical History colon surgery 2016 hernia 2021 gall bladder 05/2024 Family History Father: deceased Mother: deceased, hx of colon cancer Social History Smoking: no Recreational drug use: no. Exercise: yes. Caffeine: no. Sexually active: yes. Occupation: no. Allergies Penicillin Hospitalization/Major Diagnostic Procedure kidney stone 2025 Review of Systems 11 system Review of Systems completed in the chart and all pertinent positives and negatives reviewed with the patient ...ea. Vital Signs RR: 16, HR: 86, BP: 141/76 mm Hg, Ht: 67, Wt: 165 lb